Skip to main content
OpenTrials

Clinical trial condition

Hepatitis, Viral, Human

Explore clinical trials studying Hepatitis, Viral, Human. Study availability and eligibility vary by location and protocol.

2,934 public trials 160 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis, Viral, Human trial results

Recruiting

Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus

NCT07096193

Conditions
Chronic Disease, Chronic Hepatitis Delta, Digestive System Diseases, +12 more
Locations
  • Investigative Site Anaheim, California, United States
  • University of Louisville, Clinical Trials Unit Louisville, Kentucky, United States
  • University of Maryland, Institute of Human Virology, Clinical Research Unit Baltimore, Maryland, United States
  • The New York-Presbyterian Hospital New York, United States
View all 28 locations
View Trial Details
Recruiting

A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)

NCT07200908

Conditions
Chronic Hepatitis D Infection, Digestive System Diseases, Hepatitis, +6 more
Locations
  • Medical University of Graz Graz, Austria
  • Universitätsklinikum St. Pölten Sankt Pölten, Austria
  • Fakultni Nemocnice Brno Brno, Czechia
  • Fakultni Nemocnice Hradec Kralove Hradec Králové, Czechia
View all 53 locations
View Trial Details
Recruiting

A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection (D-clear Study)

NCT07499544

Conditions
Chronic Hepatitis D Infection, Digestive System Diseases, Hepatitis, +6 more
Locations
  • Site 201 Garden Grove, California, United States
  • Site 101 Changchun, Jilin, China
  • Site 104 Kashgar, Xinjiang Uygur Autonomous Region, China
  • Site 103 Ürümqi, Xinjiang Uygur Autonomous Region, China
View Trial Details
Recruiting

Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B

NCT06680232

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations
  • Massachusetts General Hospital/Harvard University Boston, Massachusetts, United States
  • Queen Mary Hospital, The University of Hong Kong Hong Kong
  • ICS ARENSIA Exploratory Medicine SRL Chisinau, Moldova
  • New Zealand Clinical Research Auckland, New Zealand
View Trial Details
Recruiting

Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV

NCT07040319

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • USC LA Los Angeles, California, United States
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • University of Colorado Denver Aurora, Colorado, United States
  • Univ. of Florida Jacksonville Jacksonville, Florida, United States
View Trial Details
Recruiting

The Australian HCV Point-of-Care Testing Program

NCT05042544

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Hepatitis ACT Canberra, Australian Capital Territory, Australia
  • Western NSW LHD Bathurst, New South Wales, Australia
  • Far West LHD Broken Hill, New South Wales, Australia
  • Maari Ma Health Aboriginal Corporation Broken Hill, New South Wales, Australia
View all 69 locations
View Trial Details
Recruiting

The National Australian HCV Point-of-Care Testing Program - HCV Antibody Testing Minimal Dataset

NCT05713136

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • ACT Justice Health Canberra, Australian Capital Territory, Australia
  • Justice Health and Forensic Mental Health Network Sydney, New South Wales, Australia
  • Queensland Injectors Health Network Ltd Bowen Hills, Queensland, Australia
  • West Moreton Hospital and Health Service Brisbane, Queensland, Australia
View Trial Details

Related conditions